First case of B ALL with KMT2A-MAML2 rearrangement: a case report

Estelle Menu (1) , Nathalie Beaufils (2) , Fabrice Usseglio (3) , Estelle Balducci (4) , Marina Lafage Pochitaloff (4) , Régis T Costello (5) , Jean Gabert (2)

1 Hôpital Nord [CHU - APHM]
2 Laboratoire de Biochimie et Biologie Moléculaire
3 UNIS - Inserm U1072 - Unité de Neurobiologie des canaux Ioniques et de la Synapse
4 APHM - Assistance Publique - Hôpitaux de Marseille
5 TAGC - Technologies avancées pour le génôme et la clinique

Background: A large number of chromosomal translocations of the human KMT2A gene, better known as the MLL gene, have so far been characterized. Genetic rearrangements involving KMT2A gene are frequently involved in lymphoid, myeloid and mixed lineage leukemia. One of its rare fusion partners, the mastermind like 2 (MAML2) gene has been reported in four cases of myeloid neoplasms after chemotherapy so far: two acute myeloid leukemias (AML) and two myelodysplasic syndrome (MDS), and two cases of secondary T-cell acute lymphoblastic leukemia (T-ALL). Case presentation: Here we report the case of a KMT2A - MAML2 fusion discovered by Next-Generation Sequencing (NGS) analysis in front of an inv11 (q21q23) present in a 47-year-old female previously treated for a sarcoma in 2014, who had a B acute lymphoid leukemia (B ALL). Conclusion: It is, to our knowledge, the first case of B acute lymphoblastic leukemia with this fusion gene. At the molecular level, two rearrangements were detected using RNA sequencing juxtaposing exon 7 to exon 2 and exon 9 to intron 1–2 of the KMT2A and MAML2 genes respectively, and one rearrangement using Sanger sequencing juxtaposing exon 8 and exon 2.

Domaines: Génétique humaine; Cancer; Hématologie

Estelle Menu, Nathalie Beaufils, Fabrice Usseglio, Estelle Balducci, Marina Lafage Pochitaloff, et al.. First case of B ALL with KMT2A-MAML2 rearrangement: a case report. BMC Cancer, 2017, 17, pp.363. ⟨10.1186/s12885-017-3368-4⟩. ⟨hal-01766866⟩